Uncategorized – Page 2 – SeattleNTC

Uncategorized

January 29, 2015

Repetitive Transcranial Magnetic Stimulation: A Tool for Long-Term Smoking Cessation

by Jennifer Bolton and Serena Smith, TMS Clinicians at SeattleNTC Tobacco use is the leading cause of preventable death in developed countries[1]. Despite smokers frequently identifying tobacco use as harmful and expressing a desire to reduce or stop smoking, most smokers have difficulty abstaining. Eighty-five percent of those who attempt to quit smoking without assistance relapse, with the majority resuming use within one week of quitting. Numerous aids have been helpful in increasing immediate abstinence rates, but the long-term outcomes are still disappointing.  After 6 months, common aids, such as nicotine gum and bupropion (a prescription medication) result in abstinence rates […]
October 24, 2014

Repetitive Transcranial Magnetic Stimulation and Associative Memory Enhancement

by Jennifer Bolton and Serena Smith, TMS Clinicians at SeattleNTC Transcranial magnetic stimulation (TMS), a noninvasive method of brain stimulation, has recently been shown to enhance neural pathways in the brain that are associated with memory function. In memory processing, superficial regions of the brain, such as the lateral-parietal cortex, connect to deeper memory control centers, such as the hippocampus. Because TMS can stimulate only the outer few centimeters of the human cortex, the lateral-parietal cortex has been identified as a target area over which TMS could be used to affect deeper brain structures or regions involved in memory. In a study by Wang […]
June 23, 2014

Likelihood of Remission from Depression with Medications vs. TMS vs. ECT

Depression is now the leading cause of disability in the world (WHO, 2012), and Transcranial Magnetic Stimulation (TMS) is increasingly recognized as an important treatment option by both clinicians and insurance companies As such, we are frequently asked about the relative effectiveness of medications vs. TMS vs. ECT for treatment-resistant depression.  While head to head studies of the 3 treatments have not been completed, it is interesting to compare large, multi-site, frequently cited studies of the 3 treatment modalities administered to patients with similar levels of treatment resistance. These findings are a useful reminder to regularly assess the severity of […]